Implanet enters exclusive distribution partnership for Australia, New Zealand: 4 key points

Spinal Tech

Bordeaux, France-based Implanet entered into an exclusive distribution agreement with Device Technologies for the Australia and New Zealand markets.

Here are four key points:


1. With this partnership, Implanet markets in 17 countries.


2. Implanet will now have access to Australia's $120 million vertebral fusion market, to offer its Jazz products.  


3. Implanet also integrated its Jazz Claw into the Australian Register of Therapeutic Goods.


4. Jazz is designed to treat spinal pathologies with vertebral fusion surgery.  


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers